| Original language | English |
|---|---|
| Pages (from-to) | 3-4 |
| Number of pages | 2 |
| Journal | Clinical and Experimental Neuroimmunology |
| Volume | 6 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Feb 1 2015 |
Fingerprint
Myasthenia Gravis
All Science Journal Classification (ASJC) codes
- Neuroscience (miscellaneous)
- Immunology
- Immunology and Microbiology (miscellaneous)
- Clinical Neurology
Cite this
What should we target? the beginning of a new era in the diagnosis and treatment of myasthenia gravis. / Murai, Hiroyuki.
In: Clinical and Experimental Neuroimmunology, Vol. 6, No. 1, 01.02.2015, p. 3-4.Research output: Contribution to journal › Editorial
Murai, H 2015, 'What should we target? the beginning of a new era in the diagnosis and treatment of myasthenia gravis', Clinical and Experimental Neuroimmunology, vol. 6, no. 1, pp. 3-4. https://doi.org/10.1111/cen3.12186
@article{268f55d96af74909bb996e4b5b8f5535,
title = "What should we target? the beginning of a new era in the diagnosis and treatment of myasthenia gravis",
author = "Hiroyuki Murai",
year = "2015",
month = "2",
day = "1",
doi = "10.1111/cen3.12186",
language = "English",
volume = "6",
pages = "3--4",
journal = "Clinical and Experimental Neuroimmunology",
issn = "1759-1961",
publisher = "John Wiley and Sons Ltd",
number = "1",
}
TY - JOUR
T1 - What should we target? the beginning of a new era in the diagnosis and treatment of myasthenia gravis
AU - Murai, Hiroyuki
PY - 2015/2/1
Y1 - 2015/2/1
UR - http://www.scopus.com/inward/record.url?scp=84922126911&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84922126911&partnerID=8YFLogxK
U2 - 10.1111/cen3.12186
DO - 10.1111/cen3.12186
M3 - Editorial
AN - SCOPUS:84922126911
VL - 6
SP - 3
EP - 4
JO - Clinical and Experimental Neuroimmunology
JF - Clinical and Experimental Neuroimmunology
SN - 1759-1961
IS - 1
ER -